Xencor
XNCR
#5580
Rank
โ‚น110.98 B
Marketcap
โ‚น1,554
Share price
-4.63%
Change (1 day)
-27.52%
Change (1 year)

Revenue for Xencor (XNCR)

Revenue in 2025 (TTM): โ‚น14.40 Billion

According to Xencor's latest financial reports the company's current revenue (TTM ) is โ‚น15.03 Billion. In 2024 the company made a revenue of โ‚น10.95 Billion a decrease over the revenue in the year 2023 that were of โ‚น14.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xencor from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น14.40 B31.5%
2024 โ‚น10.95 B-21.82%
2023 โ‚น14.01 B2.9%
2022 โ‚น13.61 B-33.49%
2021 โ‚น20.47 B128.2%
2020 โ‚น8.97 B-19.7%
2019 โ‚น11.17 B293.6%
2018 โ‚น2.83 B65.05%
2017 โ‚น1.72 B-71.08%
2016 โ‚น5.94 B222.37%
2015 โ‚น1.84 B205.78%
2014 โ‚น0.60 B-3.99%
2013 โ‚น0.62 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
โ‚น206.65 B 1,274.52%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
โ‚น11.31 B-24.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.231 T 21,393.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.770 T 38,282.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 54,961.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น5.358 T 35,538.78%๐Ÿ‡บ๐Ÿ‡ธ USA